Drug Profile
M 17055
Alternative Names: Alilusem; MD 31Latest Information Update: 13 Aug 2002
Price :
$50
*
At a glance
- Originator Mochida Pharmaceutical
- Class
- Mechanism of Action Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Oedema
Most Recent Events
- 07 Sep 1998 No-Development-Reported for Heart failure in Japan (Unknown route)
- 07 Sep 1998 No-Development-Reported for Hypertension in Japan (Unknown route)
- 06 Mar 1998 Phase-I clinical trials for Oedema in Japan (PO)